The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms

ABSTRACT Determination of the MIC, based on the activities of antibiotics against planktonic bacteria, is the standard assay for antibiotic susceptibility testing. Adherent bacterial populations (biofilms) present with an innate lack of antibiotic susceptibility not seen in the same bacteria grown as planktonic populations. The Calgary Biofilm Device (CBD) is described as a new technology for the rapid and reproducible assay of biofilm susceptibilities to antibiotics. The CBD produces 96 equivalent biofilms for the assay of antibiotic susceptibilities by the standard 96-well technology. Biofilm formation was followed by quantitative microbiology and scanning electron microscopy. Susceptibility to a standard group of antibiotics was determined for National Committee for Clinical Laboratory Standards (NCCLS) reference strains: Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, andStaphylococcus aureus ATCC 29213. Growth curves demonstrated that biofilms of a predetermined size could be formed on the CBD at specific time points and, furthermore, that no significant difference (P > 0.1) was seen between biofilms formed on each of the 96 pegs. The antibiotic susceptibilities for planktonic populations obtained by the NCCLS method or from the CBD were similar. Minimal biofilm eradication concentrations, derived by using the CBD, demonstrated that for biofilms of the same organisms, 100 to 1,000 times the concentration of a certain antibiotic were often required for the antibiotic to be effective, while other antibiotics were found to be effective at the MICs. The CBD offers a new technology for the rational selection of antibiotics effective against microbial biofilms and for the screening of new effective antibiotic compounds.

[1]  J. Costerton,et al.  The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.

[2]  J. Lacroix,et al.  Effects of metronidazole on Porphyromonas gingivalis biofilms. , 1997, Journal of periodontal research.

[3]  P. Stewart,et al.  Theoretical aspects of antibiotic diffusion into microbial biofilms , 1996, Antimicrobial agents and chemotherapy.

[4]  M. Wilson,et al.  Susceptibility of oral bacterial biofilms to antimicrobial agents. , 1996, Journal of medical microbiology.

[5]  N. Fiehn,et al.  Resistance of Streptococcus sanguis biofilms to antimicrobial agents , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[6]  R. Darouiche,et al.  Antibiotics and prevention of microbial colonization of catheters , 1995, Antimicrobial agents and chemotherapy.

[7]  N. Khardori,et al.  Modulation of biofilms of Pseudomonas aeruginosa by quinolones , 1995, Antimicrobial agents and chemotherapy.

[8]  H. Kumon,et al.  Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm , 1995, Antimicrobial agents and chemotherapy.

[9]  J. Costerton,et al.  Microbial Biofilms , 2011 .

[10]  D. Morck,et al.  Comparative evaluation of fleroxacin, ampicillin, trimethoprimsulfamethoxazole, and gentamicin as treatments of catheter-associated urinary tract infection in a rabbit model. , 1994, International journal of antimicrobial agents.

[11]  G. Reid,et al.  Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters , 1994, Antimicrobial Agents and Chemotherapy.

[12]  R. Auckenthaler,et al.  Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. , 1991, The Journal of infectious diseases.

[13]  A. Widmer,et al.  Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections , 1991, Antimicrobial Agents and Chemotherapy.

[14]  D. Allison,et al.  Susceptibility of bacterial biofilms to tobramycin: role of specific growth rate and phase in the division cycle. , 1990, The Journal of antimicrobial chemotherapy.

[15]  R. Cleeland,et al.  Method of evaluating effects of antibiotics on bacterial biofilm , 1987, Antimicrobial Agents and Chemotherapy.

[16]  G. Peters,et al.  Interference with granulocyte function by Staphylococcus epidermidis slime , 1986, Infection and immunity.

[17]  L. Baddour,et al.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices , 1985, Journal of clinical microbiology.

[18]  J. Nickel,et al.  Electron microscopic study of an infected Foley catheter. , 1985, Canadian journal of surgery. Journal canadien de chirurgie.

[19]  J. Costerton,et al.  Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters , 1984, Journal of clinical microbiology.

[20]  A. Bisno,et al.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces , 1982, Infection and immunity.

[21]  H. Muncie,et al.  Sequelae and management of urinary infection in the patient requiring chronic catheterization. , 1981, The Journal of urology.

[22]  J. Costerton,et al.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis , 1980, Infection and immunity.